These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55. A finite mixture survival model to characterize risk groups of neuroblastoma. Hunsberger S; Albert PS; London WB Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977 [TBL] [Abstract][Full Text] [Related]
56. Narrative review: precision medicine applications in neuroblastoma-current status and future prospects. Zhou J; Du H; Cai W Transl Pediatr; 2024 Jan; 13(1):164-177. PubMed ID: 38323175 [TBL] [Abstract][Full Text] [Related]
58. Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis. Ognibene M; De Marco P; Amoroso L; Cangelosi D; Zara F; Parodi S; Pezzolo A Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046696 [TBL] [Abstract][Full Text] [Related]